Cary Street Partners Financial »

Larimar Therapeutics shares owned by Cary Street Partners Financial

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Cary Street Partners Financial from 13F filings

Historical chart of Cary Street Partners Financial investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Cary Street Partners Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Cary Street Partners Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $259k 85k 3.05

More positions owned by Cary Street Partners Financial

Vanguard Value Etf Etf (VTV)
Apple Stock (AAPL)
Vanguard Growth Etf Etf (VUG)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Microsoft Corp Stock (MSFT)
Fairlead Tactical Sector ETF Etf (TACK)
Ishares Msci Eafe Growth Etf Etf (EFG)
Tcw Flexible Income Etf Etf (FLXR)
Ishares Msci Eafe Value Etf Etf (EFV)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Income Etf Etf (JPIE)
Amazon Stock (AMZN)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Nvidia Corporation Stock (NVDA)

View all positions for Cary Street Partners Financial

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
BlackRock
Millennium Management
AIGH Capital Management
Driehaus Capital Management
Vanguard Capital Management
DAFNA Capital Management
Goldman Sachs Group
Deep Track Capital
Rtw Investments
Woodline Partners
Geode Capital Management
Soleus Capital Management
Point72 Asset Management

View all funds holding Larimar Therapeutics